First Self-Injectable HIV Antibody May Prevent Virus Transmission
The first self-injectable HIV antibody, PRO 140, has a 98 percent success rate in reducing the virus in HIV patients’…
The first self-injectable HIV antibody, PRO 140, has a 98 percent success rate in reducing the virus in HIV patients’…